These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3896595)

  • 1. A randomized controlled trial of weight reduction and metoprolol in the treatment of hypertension in young overweight patients.
    MacMahon SW; Macdonald GJ; Bernstein L; Andrews G; Blacket RB
    Clin Exp Pharmacol Physiol; 1985; 12(3):267-71. PubMed ID: 3896595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients.
    MacMahon SW; Macdonald GJ; Bernstein L; Andrews G; Blacket RB
    Lancet; 1985 Jun; 1(8440):1233-6. PubMed ID: 2860441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of high blood pressure in overweight patients.
    MacMahon S; Macdonald G
    Nephron; 1987; 47 Suppl 1():8-12. PubMed ID: 2962005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients.
    MacMahon SW; Wilcken DE; Macdonald GJ
    N Engl J Med; 1986 Feb; 314(6):334-9. PubMed ID: 2935737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
    Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
    Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA; Tooley M; Sibbald B; Gould SE
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
    Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
    Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G; Berger J; Olsson G; Menzel T
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of captopril and metoprolol as monotherapy or combined with bendroflumethiazide on blood lipids.
    Foss OP; Jensen EK
    J Intern Med; 1990 Feb; 227(2):119-23. PubMed ID: 2405090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of indoramin and metoprolol on plasma lipids and lipoproteins.
    Martinez TL; Auriemo CR; Machado AM; Cunha MA; Feres MC; Maldjian S; Wortsman A; Delboni FO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S76-9. PubMed ID: 2423803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hypertension in elderly patients with felodipine and metoprolol: a double-blind, placebo-controlled clinical trial.
    Freeling P; Davis RH; Goves JR; Burton RH; Orme-Smith EA
    Br J Clin Pharmacol; 1987 Oct; 24(4):459-64. PubMed ID: 3318897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    Clin Pharmacol Ther; 1990 Sep; 48(3):318-24. PubMed ID: 2401129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B; Hosie J
    Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A; Baandrup S; Houtzagers J; Westergren G
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of enalapril and metoprolol as initial therapy for mild to moderate hypertension.
    Nugent LW; Miola SR; Walker JF
    J Clin Pharmacol; 1987 Jul; 27(7):461-7. PubMed ID: 2821080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.